TW238309B - - Google Patents

Info

Publication number
TW238309B
TW238309B TW081108218A TW81108218A TW238309B TW 238309 B TW238309 B TW 238309B TW 081108218 A TW081108218 A TW 081108218A TW 81108218 A TW81108218 A TW 81108218A TW 238309 B TW238309 B TW 238309B
Authority
TW
Taiwan
Application number
TW081108218A
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of TW238309B publication Critical patent/TW238309B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW081108218A 1991-10-24 1992-10-16 TW238309B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78225391A 1991-10-24 1991-10-24
US79545691A 1991-11-22 1991-11-22

Publications (1)

Publication Number Publication Date
TW238309B true TW238309B (zh) 1995-01-11

Family

ID=27119973

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081108218A TW238309B (zh) 1991-10-24 1992-10-16

Country Status (6)

Country Link
JP (1) JPH07500333A (zh)
AU (1) AU2559392A (zh)
CA (1) CA2118920A1 (zh)
MX (1) MX9205973A (zh)
TW (1) TW238309B (zh)
WO (1) WO1993008166A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512566A (en) * 1993-10-25 1996-04-30 Ortho Pharmaceutical Corporation Tricyclic compounds having affinity for the 5-HT1A receptor
CA2284732C (en) * 1997-04-07 2008-06-17 Georgetown University Analogs of cocaine
TW200924752A (en) * 2007-09-17 2009-06-16 Organon Nv Tricyclic heterocyclic derivatives
US8518933B2 (en) 2009-04-23 2013-08-27 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en) 2009-04-23 2013-10-01 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630902A5 (en) * 1977-01-24 1982-07-15 Sandoz Ag Process for preparing novel derivatives of 1,2,3,4,4a,10b-hexahydrobenzo(f)isoquinoline.
US4341786A (en) * 1981-03-02 1982-07-27 Smithkline Corporation Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds
PT77267B (en) * 1982-09-07 1986-03-21 Lilly Co Eli Improved process for preparing novel octahydrobenz <f> isoquinolines or compounds relating thereto
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
AU626621B2 (en) * 1988-12-15 1992-08-06 Abbott Laboratories Substituted hexahydro-indenopyrroles, -indenopyridines, and -benzoisoindoles as 5-ht selective agents
GB8917333D0 (en) * 1989-07-28 1989-09-13 Merck Sharp & Dohme Therapeutic agents
GB9014061D0 (en) * 1990-06-25 1990-08-15 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
MX9205973A (es) 1993-05-01
WO1993008166A1 (en) 1993-04-29
JPH07500333A (ja) 1995-01-12
AU2559392A (en) 1993-05-21
CA2118920A1 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
FR2683960B1 (zh)
EP0529234A3 (zh)
EP0530988A3 (zh)
EP0512225A3 (zh)
DE4291050T1 (zh)
DE4291684T1 (zh)
EP0529093A4 (zh)
EP0503606A3 (zh)
DE4290056T1 (zh)
EP0501430A3 (zh)
EP0528051A4 (zh)
DE4292012T1 (zh)
FR2684140B1 (zh)
ECSM91545U (zh)
ECSM91533U (zh)
EP0508059A3 (zh)
EP0520400A3 (zh)
EP0500398A3 (zh)
CN3009798S (zh)
EP0501617A3 (zh)
EP0502497A3 (zh)
CN3009748S (zh)
EP0507384A3 (zh)
CN3008237S (zh)
EP0509424A3 (zh)